NM_000179.3(MSH6):c.3622dup (p.Ser1208fs) AND Lynch syndrome 5
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Aug 24, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003451257.1
Allele description [Variation Report for NM_000179.3(MSH6):c.3622dup (p.Ser1208fs)]
NM_000179.3(MSH6):c.3622dup (p.Ser1208fs)
Condition(s)
-
Literature Search Strategy - Clinical Review Report: Empagliflozin (Jardiance)
Literature Search Strategy - Clinical Review Report: Empagliflozin (Jardiance)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 8, 2024